Drugs / Chinese medicine
Chinese medicine
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05613062 | Apr → Dec 2023 | atopic eczema | Chinese University of Hong Kong | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06074809 | Nov 2023 → Oct 2025 | — | Chinese University of Hong Kong | Unknown | No outcome recorded |
| Phase 2 | NCT01682551 | Sep 2012 | acute mountain sickness | China Medical University Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06467942 Comparator | Mar 2023 → Dec 2024 | human papilloma virus infection | Peking University People's Hospital | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chinese medicine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06467942 ↗ |
| Known as | Modified Guizhi Fuling granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06074809 ↗ |
| Known as | Modified Huang-Lian-Jie-Du Decoction (MHLJDD) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05613062 ↗ |
| Known as | Wu Zhu Yu Tang | “Chinese medicine prescription "Wu Zhu Yu Tang" can prevent Acute Mountain Sickness(AMS)” NCT01682551 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese medicine prescription "Wu Zhu Yu Tang"” NCT01682551 ↗ |
| Route | Oral | “will take 2g (powder in capsule) of "Wu Zhu Yu Tang" or placebo orally three times in the first day and one time in the second day” NCT01682551 ↗ |